Bell Potter

Reported net loss $9.1m (IPO listing costs and Musashi integration costs) | Full year China sales $22.0m, up 38.4% on the pcp |EBIT up 4% to $20.8m .Proforma Segment Performance: Vitamins and Dietary supplements- Revenue up 26%, EBIT up 50.4% to $17.0m, margin 17%; Sports and Nutrition- Revenue up 21.6%, EBIT down 9.6% to $17.7m, margin 15.8% | Net operating cash flow $4.7m, as compared to $14.8m in pcp.


Please sign in to comment on this wire.